Moxibustion pre-treatment attenuates seizure severity during status epilepticus and counteracts the proconvulsant function of the purinergic P2X7 receptor-Reference-Cited by-同舟云学术

Moxibustion pre-treatment attenuates seizure severity during status epilepticus and counteracts the proconvulsant function of the purinergic P2X7 receptor

Published:2024-09-13 Issue: Volume: Page:
ISSN:1573-9538
Container-title:Purinergic Signalling
language:en
Short-container-title:Purinergic Signalling

Author:

Zhang Hong-Wei,Li Jia-Jia,Tang Yulihan,Tian Mao-Lin,Huang Sheng,Sun Meng-Juan

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11302-024-10050-x.pdf

Reference31 articles.

1. Fisher RS, van Emde BW, Blume W, Elger C, Genton P, Lee P, Engel J Jr (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46(4):470–472. https://doi.org/10.1111/j.0013-9580.2005.66104.x

2. Asadi-Pooya AA, Brigo F, Lattanzi S, Blumcke I (2023) Adult epilepsy. Lancet (London, England) 402(10399):412–424. https://doi.org/10.1016/S0140-6736(23)01048-6

3. Hu T, Zhang J, Wang J, Sha L, Xia Y, Ortyl TC, Tian X, Chen L (2023) Advances in epilepsy: mechanisms, clinical trials, and drug therapies. J Med Chem 66(7):4434–4467. https://doi.org/10.1021/acs.jmedchem.2c01975

4. Beamer E, Fischer W, Engel T (2017) The ATP-gated P2X7 receptor as a target for the treatment of drug-resistant epilepsy. Front Neurosci 11:21. https://doi.org/10.3389/fnins.2017.00021

5. Smith J, Menéndez Méndez A, Alves M, Parras A, Conte G, Bhattacharya A, Ceusters M, Nicke A, Henshall DC, Jimenez-Mateos EM, Engel T (2023) The P2X7 receptor contributes to seizures and inflammation-driven long-lasting brain hyperexcitability following hypoxia in neonatal mice. Br J Pharmacol 180(13):1710–1729. https://doi.org/10.1111/bph.16033